2-{N-[-(1-Benzylpiperidin-4-yl)alkyl]amino}-6-[(prop-2-yn-1-yl)amino]pyridine-3,5-dicarbonitriles Showing High Affinity for 1/2 Receptors.

W. Deuther-Conrad, D. Schepmann, I. Iriepa, F. López-Munoz, M. Chioua, B. Wünsch, A. Samadi, J. Marco-Contelles, (2025)

In: International Journal of Molecular Sciences, 26.

Forschungsartikel (Zeitschrift)

Stereoselective synthesis and biological evaluation of perhydroquinoxaline-based kappa receptor agonists.

J. Hoffmann, D. Schepmann, C. Daniliuc, M. Bermúdez, B. Wünsch (2025)

In: International Journal of Molecular Sciences, 26.

Forschungsartikel (Zeitschrift)

Fluorescent probes to image the KCa3.1 channel in tumor cells.

I. Thale, E. Naß, L. Vinnenberg, L. M. Todesca, T. Budde, I. Maisuls, C. A. Strassert, A. Schwab, B. Wünsch (2025)

In: Pharmaceutics, 17.

Forschungsartikel (Zeitschrift)

[18F]Fluspidine – a PET tracer for imaging of 1 receptors in the central nervous system

In: .

A novel fluorescent labeling compound for GluN2A containing N-methyl-D-aspartate receptors identified by autodisplay-based screening.

In: , .

Publikationen

Betrieben von

Top-Links

Synthesis of piperazine-based fluorinated fibroblast activation protein inhibitors for the development of a novel 18F-labeled PET imaging probe. Köchel R; Wagner S; Schwegmann K; Schäfers M; Breyholz HJ; Wünsch B (2025) In: European Journal of Medicinal Chemistry, 290. Forschungsartikel (Zeitschrift)
2-{N-[-(1-Benzylpiperidin-4-yl)alkyl]amino}-6-[(prop-2-yn-1-yl)amino]pyridine-3,5-dicarbonitriles Showing High Affinity for 1/2 Receptors. W. Deuther-Conrad, D. Schepmann, I. Iriepa, F. López-Munoz, M. Chioua, B. Wünsch, A. Samadi, J. Marco-Contelles, (2025) In: International Journal of Molecular Sciences, 26. Forschungsartikel (Zeitschrift)
Synthesis and structure-affinity relationships of spirocyclic 1 receptor ligands with tetrahydropyran scaffold. T. Winge, D. Schepmann, J. Schmidt, B. Wünsch (2025) In: European Journal of Medicinal Chemistry, 281, 117002. Forschungsartikel (Zeitschrift)
Stereoselective synthesis and biological evaluation of perhydroquinoxaline-based kappa receptor agonists. J. Hoffmann, D. Schepmann, C. Daniliuc, M. Bermúdez, B. Wünsch (2025) In: International Journal of Molecular Sciences, 26. Forschungsartikel (Zeitschrift)
Structure activity relationship studies of tetracyclic pyrrolocarbazoles inhibiting heterotetrameic proteinkinase CK2. L. Kröger, S. Borgert, M. Lauwers, M. Steinkrüger, J. Jose, M. Pietsch, B. Wünsch (2025) In: Molecules, 30. Forschungsartikel (Zeitschrift)
Fluorescent probes to image the KCa3.1 channel in tumor cells. I. Thale, E. Naß, L. Vinnenberg, L. M. Todesca, T. Budde, I. Maisuls, C. A. Strassert, A. Schwab, B. Wünsch (2025) In: Pharmaceutics, 17. Forschungsartikel (Zeitschrift)
Novel [18F]Fluorine-Based PET Tracers with Polar But Nonbasic Linkers to Image the Fibroblast Activation Protein in the Microenvironment of Tumors. In: .
[18F]Fluspidine – a PET tracer for imaging of 1 receptors in the central nervous system In: .
Late-stage diversification of pyrazoles as antileishmanial agents. In: , .
A novel fluorescent labeling compound for GluN2A containing N-methyl-D-aspartate receptors identified by autodisplay-based screening. In: , .